Sort   by:  
 Page size 
UnknownPhase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx--TPF-C-HIT.
Not available
S-EPMC3118195 | biostudies-literature
UnknownPhysiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?
Not available
S-EPMC2921920 | biostudies-literature
UnknownAssessment of Quality of Life in Postmenopausal Women with Early Breast Cancer Participating in the PACT Trial: The Impact of Additional Patient Information Material Packages and Patient Compliance.
Not available
S-EPMC7383248 | biostudies-literature
UnknownPatient's Anastrozole Compliance to Therapy (PACT) Program: Baseline Data and Patient Characteristics from a Population-Based, Randomized Study Evaluating Compliance to Aromatase Inhibitor Therapy in Postmenopausal Women with Hormone-Sensitive Early Breast Cancer.
Not available
S-EPMC3683950 | biostudies-literature
UnknownGenomewide scan in german families reveals evidence for a novel psoriasis-susceptibility locus on chromosome 19p13.
Not available
S-EPMC1287873 | biostudies-literature
UnknownReal-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap Study.
Not available
S-EPMC9324206 | biostudies-literature
UnknownVEGFA GENE variation influences hallucinations and frontotemporal morphology in psychotic disorders: a B-SNIP study.
Not available
S-EPMC6181939 | biostudies-literature
UnknownMultivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia.
Not available
S-EPMC4024891 | biostudies-literature
UnknownGene expression profiling at birth characterizing the preterm infant with early onset infection.
Not available
S-EPMC5239802 | biostudies-literature
UnknownDesign and rationale of MYOFLAME-19 randomised controlled trial: MYOcardial protection to reduce post-COVID inFLAMmatory heart disease using cardiovascular magnetic resonance Endpoints.
Not available
S-EPMC11697771 | biostudies-literature
Sort   by:  
 Page size